Specificity | Clone | Host Species | Reactive Species | Format | Size | |
---|---|---|---|---|---|---|
HER2 (Trastuzumab biosimilar) | Trastuzumab | Human | human | unconjugated | 50 mg | More Info |
HER2 (Trastuzumab biosimilar) | Trastuzumab | Human | human | unconjugated | 5 mg | More Info |
6-His | 6-His | Mouse | n/a | unconjugated | 1 mg | More Info |
6-His | 6-His | Mouse | n/a | unconjugated | 25 mg | More Info |
6-His | 6-His | Mouse | n/a | unconjugated | 5 mg | More Info |
HIV gp120 | 55-36 | Mouse | n/a | unconjugated | 100 mg | More Info |
HIV gp120 | 55-36 | Mouse | n/a | unconjugated | 1 mg | More Info |
HIV gp120 | 55-36 | Mouse | n/a | unconjugated | 25 mg | More Info |
HIV gp120 | 55-36 | Mouse | n/a | unconjugated | 50 mg | More Info |
HIV gp120 | 55-36 | Mouse | n/a | unconjugated | 5 mg | More Info |
ICOS | C398.4A | Armenian Hamster | human, monkey, mouse, rat | unconjugated | 100 mg | More Info |
ICOS | C398.4A | Armenian Hamster | human, monkey, mouse, rat | unconjugated | 1 mg | More Info |
ICOS | C398.4A | Armenian Hamster | human, monkey, mouse, rat | unconjugated | 25 mg | More Info |
ICOS | C398.4A | Armenian Hamster | human, monkey, mouse, rat | unconjugated | 50 mg | More Info |
ICOS | C398.4A | Armenian Hamster | human, monkey, mouse, rat | unconjugated | 5 mg | More Info |
ICOS | 7E.17G9 | Rat | mouse | unconjugated | 100 mg | More Info |
ICOS | 7E.17G9 | Rat | mouse | unconjugated | 1 mg | More Info |
ICOS | 7E.17G9 | Rat | mouse | unconjugated | 25 mg | More Info |
ICOS | 7E.17G9 | Rat | mouse | unconjugated | 50 mg | More Info |
ICOS | 7E.17G9 | Rat | mouse | unconjugated | 5 mg | More Info |
ICOSL | HK5.3-CP044 | Recombinant Mouse | mouse | unconjugated | 1 mg | More Info |
ICOSL | HK5.3 | Rat | mouse | unconjugated | 100 mg | More Info |
ICOSL | HK5.3 | Rat | mouse | unconjugated | 1 mg | More Info |
ICOSL | HK5.3 | Rat | mouse | unconjugated | 25 mg | More Info |
ICOSL | HK5.3 | Rat | mouse | unconjugated | 50 mg | More Info |
ICOSL | HK5.3 | Rat | mouse | unconjugated | 5 mg | More Info |
ICOSL | HK5.3-CP045 | Recombinant Mouse | mouse | unconjugated | 1 mg | More Info |
ICOSL | HK5.3-CP046 | Recombinant Mouse | mouse | unconjugated | 1 mg | More Info |
IFNAR-1 | MAR1-5A3 | Mouse | mouse | unconjugated | 100 mg | More Info |
IFNAR-1 | MAR1-5A3 | Mouse | mouse | unconjugated | 1 mg | More Info |
IFNAR-1 | MAR1-5A3 | Mouse | mouse | unconjugated | 25 mg | More Info |
IFNAR-1 | MAR1-5A3 | Mouse | mouse | unconjugated | 50 mg | More Info |
IFNAR-1 | MAR1-5A3 | Mouse | mouse | unconjugated | 5 mg | More Info |
IFNAR-1 | MAR1-5A3 | Mouse | mouse | unconjugated | 100 mg | More Info |
IFNAR-1 | MAR1-5A3 | Mouse | mouse | unconjugated | 25 mg | More Info |
IFNAR-1 | MAR1-5A3 | Mouse | mouse | unconjugated | 50 mg | More Info |
IFNAR-1 | MAR1-5A3 | Mouse | mouse | unconjugated | 5 mg | More Info |
IFNAR1 (Anifrolumab biosimilar) | Anifrolumab | Human | human | unconjugated | 100 mg | More Info |
IFNAR1 (Anifrolumab biosimilar) | Anifrolumab | Human | human | unconjugated | 1 mg | More Info |
IFNAR1 (Anifrolumab biosimilar) | Anifrolumab | Human | human | unconjugated | 25 mg | More Info |
IFNAR1 (Anifrolumab biosimilar) | Anifrolumab | Human | human | unconjugated | 50 mg | More Info |
IFNAR1 (Anifrolumab biosimilar) | Anifrolumab | Human | human | unconjugated | 5 mg | More Info |
IFNγ | H22 | Armenian Hamster | mouse | unconjugated | 100 mg | More Info |
IFNγ | H22 | Armenian Hamster | mouse | unconjugated | 1 mg | More Info |
IFNγ | H22 | Armenian Hamster | mouse | unconjugated | 25 mg | More Info |
IFNγ | H22 | Armenian Hamster | mouse | unconjugated | 50 mg | More Info |
IFNγ | H22 | Armenian Hamster | mouse | unconjugated | 5 mg | More Info |
IFNγ | B133.5 | Mouse | human | unconjugated | 100 mg | More Info |
IFNγ | B133.5 | Mouse | human | unconjugated | 1 mg | More Info |
IFNγ | B133.5 | Mouse | human | unconjugated | 25 mg | More Info |